EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

miR-21a-5p targets DDX58 to suppress TLR2/NF-κB signaling and protect the blood–brain barrier after injury

Jing Yang, Ning Tang, Ruanxian Dai, Hao Fu, Shiyi Li, Qiang Meng

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-13010-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Jing Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Yan'an Hospital of Kunming City, Yan'an Hospital affiliated to Kunming Medical University, Kunming, 650051, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, MicroRNAs, NF-kappa B, Toll-Like Receptor 2. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Brain Science Application Association clinical research support program for young and middle-aged doctors in neurology, Joint Fund of Yunnan Provincial Science and Technology and Kunming Medical University, Kunming University of Science and Technology medical joint project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Damage to the blood-brain barrier (BBB) plays a pivotal role in the pathogenesis of various neurological disorders. miR-21a-5p has been implicated in the modulation of BBB injury. Understanding the molecular targets of miR-21a-5p is crucial for developing targeted interventions in BBB repair.

Methods

The target gene of miR-21a-5p was identified through bioinformatics analysis and validated using a dual luciferase reporter assay. The expression of target gene was further confirmed in both in vivo and in vitro models of BBB injury. BBB injury cell models were employed to assess the effects of target gene overexpression and silencing on brain microvascular endothelial cell (BMEC) activity, as well as on the TLR2/NF-κB signaling pathway and associated BBB proteins. miR-21a-5p overexpression and silencing were utilized to assess the impact of target gene on BBB integrity.

Results

DDX58 was identified as a direct target of miR-21a-5p and is shown to modulate BBB injury. DDX58 expression was found to be upregulated in models of BBB damage. Exosomes containing miR-21a-5p mitigated BBB damage, which was associated with downregulated DDX58 expression in vivo and in vitro. Overexpression of DDX58 in BMECs resulted in reduced cellular viability, increased expression of TLR2 and phosphorylated p65 (p-p65), as well as elevated levels of matrix metalloproteinases (MMP-2/9), which are associated with BBB disruption. This was accompanied by a reduction in tight junction proteins, including claudin-5, occludin, and ZO-1. Conversely, silencing DDX58 expression exhibited the opposite effects. Both miR-21a-5p treatment and DDX58 interference alleviated BBB injury. Co-overexpression of DDX58 during miR-21a-5p treatment reversed the protective effects of miR-21a-5p, exacerbating BBB injury. Conclusion miR-21a-5p targets and downregulates DDX58, which is associated with reduced expression of TLR2/NF-κB-related markers, decreased MMP-2/9 levels, and protection of tight junction integrity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierMicroRNAsNF-kappa BToll-Like Receptor 2DEAD-box RNA HelicasesAnimalsSignal TransductionMatrix Metalloproteinase 9Endothelial CellsRatsMatrix Metalloproteinase 2HumansMaleRats, Sprague-Dawley

Stichwörter der Autor:innen

Blood-brain barrierDDX58MMP-2/9TLR2/NF-κB pathwayTight junction proteinsmiR-21a-5p

Substanzen

MicroRNAsNF-kappa BToll-Like Receptor 2DEAD-box RNA HelicasesMatrix Metalloproteinase 9mirn21 microRNA, ratMatrix Metalloproteinase 2Tlr2 protein, rat

Autor:innen und Institutionen

  • Department of Intensive Care Unit, Yan'an Hospital of Kunming City, Yan'an Hospital affiliated to Kunming Medical University, Kunming, 650051, China.
  • Department of Neurology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Rd, Xishan district, Kunming, 650032, Yunnan Province, China.
  • Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, China.
  • College of Science, Minzu University of China, Beijing, 10081, China.
  • Department of Neurology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Rd, Xishan district, Kunming, 650032, Yunnan Province, China. m…

Förderung

  • Guangdong Brain Science Application Association clinical research support program for young and middle-aged doctors in neurology
  • Joint Fund of Yunnan Provincial Science and Technology and Kunming Medical University
  • Kunming University of Science and Technology medical joint project
  • Yunnan Provincial Clinical Medical Center for Spine and Spinal Cord Diseases Open Subjects
  • National Natural Science Foundation of China

Zitieren

APA

Yang, J., Tang, N., Dai, R., Fu, H., Li, S., & Meng, Q. (2026). miR-21a-5p targets DDX58 to suppress TLR2/NF-κB signaling and protect the blood–brain barrier after injury. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-13010-3

Vancouver

Yang J, Tang N, Dai R, Fu H, Li S, Meng Q. miR-21a-5p targets DDX58 to suppress TLR2/NF-κB signaling and protect the blood–brain barrier after injury. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-13010-3

BibTeX
@article{Yang2026,
  author = {Yang, Jing and Tang, Ning and Dai, Ruanxian and Fu, Hao and Li, Shiyi and Meng, Qiang},
  title = {miR-21a-5p targets DDX58 to suppress TLR2/NF-κB signaling and protect the blood–brain barrier after injury},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-13010-3}
}
Kostenlos starten →